• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

《人胚胎干细胞来源的子宫内膜膜类器官联合三维基质胶用于宫腔粘连综合征子宫内膜再生》的勘误[《生物活性材料》6(2021)3935 - 3946]

Corrigendum to 'Endometrial membrane organoids from human embryonic stem cell combined with the 3D Matrigel for endometrium regeneration in asherman syndrome' [Bioactive Mater. 6 (2021) 3935-3946].

作者信息

Jiang Xiuxiu, Li Xingmiao, Fei Xiangwei, Shen Jiajie, Chen Jianhua, Guo Meijun, Li Yangyang

机构信息

Department of Gynecology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, 310006, China.

Key Laboratory of Women's Reproductive Health Research of Zhejiang Province, Women's Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, 310006, China.

出版信息

Bioact Mater. 2021 May 15;6(12):4591. doi: 10.1016/j.bioactmat.2021.04.035. eCollection 2021 Dec.

DOI:10.1016/j.bioactmat.2021.04.035
PMID:34095618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8141502/
Abstract

[This corrects the article DOI: 10.1016/j.bioactmat.2021.04.006.].

摘要

[本文更正了文章的数字对象标识符：10.1016/j.bioactmat.2021.04.006。]

相似文献

1
Corrigendum to 'Endometrial membrane organoids from human embryonic stem cell combined with the 3D Matrigel for endometrium regeneration in asherman syndrome' [Bioactive Mater. 6 (2021) 3935-3946].《人胚胎干细胞来源的子宫内膜膜类器官联合三维基质胶用于宫腔粘连综合征子宫内膜再生》的勘误[《生物活性材料》6(2021)3935 - 3946]
Bioact Mater. 2021 May 15;6(12):4591. doi: 10.1016/j.bioactmat.2021.04.035. eCollection 2021 Dec.
2
Endometrial membrane organoids from human embryonic stem cell combined with the 3D Matrigel for endometrium regeneration in asherman syndrome.人胚胎干细胞来源的子宫内膜膜类器官联合3D基质胶用于宫腔粘连综合征的子宫内膜再生
Bioact Mater. 2021 Apr 16;6(11):3935-3946. doi: 10.1016/j.bioactmat.2021.04.006. eCollection 2021 Nov.
3
Erratum regarding missing Declaration of Competing Interest statements in previously published articles.关于先前发表文章中缺失利益冲突声明的勘误。
Bioact Mater. 2020 Dec 4;6(6):1789-1790. doi: 10.1016/j.bioactmat.2020.11.009. eCollection 2021 Jun.
4
Erratum regarding missing Declaration of Competing Interest statements in previously published articles.关于之前发表文章中缺失利益冲突声明的勘误。
Bioact Mater. 2020 Dec 5;6(6):1810. doi: 10.1016/j.bioactmat.2020.11.010. eCollection 2021 Jun.
5
Corrigendum to 'Application of bioactive hydrogels combined with dental pulp stem cells for the repair of large gap peripheral nerve injuries' [Bioactive Mater. 6 (3) (2021) 638-654].《生物活性水凝胶联合牙髓干细胞在修复大间隙周围神经损伤中的应用》的勘误[《生物活性材料》6(3)(2021)638 - 654]
Bioact Mater. 2021 May 29;7:2. doi: 10.1016/j.bioactmat.2021.04.034. eCollection 2022 Jan.
6
Corrigendum to "Injectable muscle-adhesive antioxidant conductive photothermal bioactive nanomatrix for efficiently promoting full-thickness skeletal muscle regeneration" [Bioact Mater, 6(2021)1605-1617].《用于高效促进全层骨骼肌再生的可注射肌肉粘附性抗氧化导电光热生物活性纳米基质》[《生物活性材料》，6(2021)1605 - 1617]的勘误
Bioact Mater. 2021 Apr 29;6(12):4319-4320. doi: 10.1016/j.bioactmat.2021.04.011. eCollection 2021 Dec.
7
Corrigendum to 'Phosphorylation inhibition of protein-tyrosine phosphatase 1B tyrosine-152 induces bone regeneration coupled with angiogenesis for bone tissue engineering' [Bioactive Mater. Vol. 6, Issue 7, Pages 2039-2057].《“蛋白酪氨酸磷酸酶1B的酪氨酸-152磷酸化抑制诱导骨再生并伴有血管生成用于骨组织工程”的勘误》[《生物活性材料》第6卷，第7期，第2039 - 2057页]
Bioact Mater. 2021 Mar 10;6(10):3192-3193. doi: 10.1016/j.bioactmat.2021.02.036. eCollection 2021 Oct.
8
Corrigendum to "Degradation of 3D-printed magnesium phosphate ceramics in vitro and a prognosis on their bone regeneration potential" [Bioact. Mater. 19 (2023) 376-391/22].《“3D打印磷酸镁陶瓷的体外降解及其骨再生潜力的预后”的勘误》[生物活性材料19 (2023) 376 - 391/22]
Bioact Mater. 2022 May 18;20:41. doi: 10.1016/j.bioactmat.2022.05.014. eCollection 2023 Feb.
9
Corrigendum to "Development of methods for detecting the fate of mesenchymal stem cells regulated by bone bioactive materials" [Bioact. Mater. 6(3) (2021) 613-626].《骨生物活性材料调控间充质干细胞命运检测方法的进展》[《生物活性材料》6(3) (2021) 613 - 626]的勘误
Bioact Mater. 2022 Dec 26;24:251. doi: 10.1016/j.bioactmat.2022.12.011. eCollection 2023 Jun.
10
Corrigendum to "3D-printed tri-element-doped hydroxyapatite/ polycaprolactone composite scaffolds with antibacterial potential for osteosarcoma therapy and bone regeneration" [Bioact. Mater. 31 (January 2024) 18-37].《具有骨肉瘤治疗和骨再生抗菌潜力的3D打印三元掺杂羟基磷灰石/聚己内酯复合支架》勘误 [生物活性材料 31（2024年1月）18 - 37]
Bioact Mater. 2024 Feb 16;35:445-446. doi: 10.1016/j.bioactmat.2023.11.018. eCollection 2024 May.